Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shiweijisheng is a Traditional Chinese Medicine (TCM) herbal prescription (decoction) primarily investigated for its potential to improve reproductive outcomes in women with repeated embryo implantation failure (RIF). Developed or utilized by researchers at the Affiliated Tongji Hospital of Tongji Medical College, the formula is often studied in conjunction with acupuncture. It is hypothesized to enhance endometrial receptivity and improve the live birth rate during assisted reproductive technology (ART) procedures. As a "Shiwei" (ten-ingredient) formula, it likely contains a standardized combination of herbs such as *Taxillus chinensis* (Sangjisheng) intended to support renal function and uterine health according to TCM principles.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on shiweijisheng.